[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits alpha-Synuclein Oligomer Formation: Relevance to Parkinson’s Disease.

Bharathi, S. G. and Parvathy, K. S. and Srinivas, P. and Indi, S. S. and Rao, K. S. (2012) Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits alpha-Synuclein Oligomer Formation: Relevance to Parkinson’s Disease. Current Pharmaceutical Design, 18. pp. 76-84.

[img] PDF
Current_Pharmaceutical_Design_2012_18_1_76-84.pdf - Published Version
Restricted to Registered users only

Download (747kB)

Abstract

alpha-Synuclein aggregation is centrally implicated in Parkinson’s disease (PD). It involves multi-step nucleated polymerization process via the formation of dimers, soluble toxic oligomers and insoluble fibrils. In the present study, we synthesized a novel compound viz., Curcumin-glucoside (Curc-gluc), a modified form of curcumin and studied its anti-aggregating potential with alpha-synuclein. Under aggregating conditions in vitro, Curc-gluc prevents oligomer formation as well as inhibits fibril formation indicating favorable stoichiometry for inhibition. The binding efficacies of Curc-gluc to both

Item Type: Article
Uncontrolled Keywords: Alpha-synuclein, Parkinson’s disease, curcumin-glucoside, oligomer, aggregation
Subjects: 600 Technology > 01 Medical sciences
600 Technology > 08 Food technology > 30 Spices/Condiments
Divisions: Dept. of Biochemistry
Plantation Products Spices and Flavour Technology
Depositing User: Food Sci. & Technol. Information Services
Date Deposited: 11 Mar 2013 05:48
Last Modified: 11 Mar 2013 05:48
URI: http://ir.cftri.com/id/eprint/11140

Actions (login required)

View Item View Item